Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Acute Myelogenous Leukemia
>>
AKT inhib
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
3
6
9
12
15
18
21
24
27
30
Epidaza
(chidamide) / Chipscreen
Estybon
(rigosertib) / Onconova, SymBio Pharma, Knight Therap
7-Hydroxystaurosporine
(UCN-01) / National Cancer Institute
MK-2206
/ Merck (MSD)
Turalio
(pexidartinib) / Daiichi Sankyo
dordaviprone
(ONC201) / Chimerix
perifosine
(D21266) / AEterna Zentaris
triciribine phosphate
(PTX-200) / VioQuest, Prescient Therap
Hocena
(antroquinonol) / Golden Biotechnology
Viracept
(nelfinavir) / ViiV Healthcare, Roche
luxeptinib
(CG-806) / Aptose Biosci
uprosertib
(LAE003) / Laekna Therap
